Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Saturday, October 11, 2008, 11:10AM ET - U.S. Markets Closed. Dow Down 1.49% Nasdaq Up 0.27%
Nanosphere, Inc. (NSPH)On Oct 10: 6.18  Down 0.43 (6.51%)  
MORE ON NSPH
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Nanosphere, Inc.
4088 Commercial Avenue
Northbrook, IL 60062
United States - Map
Phone: 847-400-9000
Fax: 847-400-9199
Web Site: http://www.nanosphere.us

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Instruments & Supplies
Full Time Employees:103

BUSINESS SUMMARY 
Nanosphere, Inc., a development stage company, develops, manufactures, and markets a molecular diagnostics platform, the Verigene System, which enables genomic and protein testing on a single platform. Its proprietary nanoparticle technology provides the ability to run multiple tests at the same time on the same sample, and enables the development of various test assays to be performed on a single platform. The company is developing diagnostic tests for a range of medical conditions, including cancer, neurodegenerative, cardiovascular, and infectious diseases, as well as pharmaco-genomics or tests for personalized medicine. It is also developing tests for genomic assays, including hyper-coagulation, warfarin metabolism, cystic fibrosis, herpes simplex virus, human papillomavirus, and respiratory virus panel; and protein assays, such as prostate specific antigen, cardiac troponin, and biomarker validation. Nanosphere was founded in 1998 and is headquartered in Northbrook, Illinois.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Nanosphere, Inc.


    CORPORATE GOVERNANCE 
    Nanosphere, Inc.'s Corporate Governance Quotient (CGQ®) as of 1-Oct-08 is better than 0.7% of Russell 3000 companies and 2.9% of Pharmaceuticals, Biotechnology & Life Sciences companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. William P. Moffitt III, 61
    Chief Exec. Officer, Pres
    $ 2.93MN/A
    Dr. Chad Mirkin Ph.d., 44
    Co-Founder, Director and Member of Scientific Advisory Board
    N/A N/A
    Mr. J. Roger Moody Jr., 40
    Chief Financial Officer, VP of Fin. & Admin., Sec. and Treasurer
    $ 234.00KN/A
    Mr. William H. Cork , 48
    Chief Technology Officer and VP of R&D
    N/A N/A
    Dr. Gregory W. Shipp M.D., 51
    Chief Medical Officer and Vice Pres of Medical, Regulatory Affairs & Quality Assurance
    N/A N/A
    Dollar amounts are as of 31-Dec-07 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis